Global Biopharmaceutical CMO And CRO Market Size study, by Source (Mammalian, Non-mammalian), By Service (Contract Manufacturing, Contract Research), By Product (Biologics, Biosimilars) and Regional Forecasts 2021-2027

BIZ4899766
200 Pages
January 2022
Medical Devices

Download Sample Get Discount

Global Biopharmaceutical CMO And CRO Market is valued at approximately USD 27.6 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 6.6 % over the forecast period 2021-2027. Biopharmaceutical CMO And CRO are contract manufacturing organizations and contract research organizations. It basically provides research and development services and focuses on manufacturing. The rising demand for biopharmaceuticals has led to the adoption of Biopharmaceutical CMO And CRO across the forecast period. For Instance: according to the Information Technology & Innovation Foundation in 2020, the demand and adoption of biopharmaceutical industries is increasing rapidly worldwide. As per the source, the industry is contributing a huge amount to the U.S economy and providing employment to around 50,0000 workers. The source also states that due to increasing demand China is striving to become the leading region in biopharmaceuticals. Increasing investment by CMOs for capacity expansion enhances the market growth of Biopharmaceutical CMO And CRO. Also, with the rising investment in pharmaceutical industry, the adoption & demand for Biopharmaceutical CMO And CRO is likely to increase the market growth during the forecast period. However, limited outsourcing amongst well-established biopharmaceutical manufacturers impedes the growth of the market over the forecast period of 2021-2027.

The geographical regions considered for the global Biopharmaceutical CMO And CRO market analysis include Asia Pacific, North America, Europe, Latin America and Rest of the World. North America dominated the market across the world for Biopharmaceutical CMO And CRO and projected the largest revenue share owing to the presence of small and mid-size biopharmaceutical industries and well-equipped resources. Whereas, Asia-Pacific is also estimated to be the rapidly growing region during 2021-2027. The Biopharmaceutical CMO And CRO market is tremendously growing because of factors such as lower operating costs and labor costs.

Major market players included in this report are:

Boehringer Ingelheim GmbH

Lonza Group AG

Inno Biologics Sdn Bhd

Rentschler Biopharma SE

JRS Pharma

Biomeva GmbH

ProBioGen AG

Fujifilm Diosynth Biotechnologies U.S.A., Inc.

Toyobo Co., Ltd.

Samsung Biologics

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Source:

Mammalian

Non-mammalian

By Service:

Contract Manufacturing

Contract Research

By Product:

Biologics

Biosimilars

By Region:

North America

U.S.

Canada

Europe

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019

Base year – 2020

Forecast period – 2021 to 2027

Target Audience of the Global Biopharmaceutical CMO And CRO Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Chapter 1. Executive Summary

1.1. Market Snapshot

1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)

1.2.1. Global Biopharmaceutical CMO And CRO Market, by Region, 2019-2027 (USD Billion)

1.2.2. Global Biopharmaceutical CMO And CRO Market, by Source, 2019-2027 (USD Billion)

1.2.3. Global Biopharmaceutical CMO And CRO Market, by Service, 2019-2027 (USD Billion)

1.2.4. Global Biopharmaceutical CMO And CRO Market, by Product, 2019-2027 (USD Billion)

1.3. Key Trends

1.4. Estimation Methodology

1.5. Research Assumption

Chapter 2. Global Biopharmaceutical CMO And CRO Market Definition and Scope

2.1. Objective of the Study

2.2. Market Definition & Scope

2.2.1. Scope of the Study

2.2.2. Industry Evolution

2.3. Years Considered for the Study

2.4. Currency Conversion Rates

Chapter 3. Global Biopharmaceutical CMO And CRO Market Dynamics

3.1. Biopharmaceutical CMO And CRO Market Impact Analysis (2019-2027)

3.1.1. Market Drivers

3.1.1.1. Rising demand for the biopharmaceuticals

3.1.1.2. Increasing investment by CMOs for capacity expansion

3.1.2. Market Challenges

3.1.2.1. Limited outsourcing amongst well-established biopharmaceutical manufacturers

3.1.3. Market Opportunities

3.1.3.1. Rising investment in pharmaceutical industry

Chapter 4. Global Biopharmaceutical CMO And CRO Market Industry Analysis

4.1. Porter’s 5 Force Model

4.1.1. Bargaining Power of Suppliers

4.1.2. Bargaining Power of Buyers

4.1.3. Threat of New Entrants

4.1.4. Threat of Substitutes

4.1.5. Competitive Rivalry

4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)

4.2. PEST Analysis

4.2.1. Political

4.2.2. Economical

4.2.3. Social

4.2.4. Technological

4.3. Investment Adoption Model

4.4. Analyst Recommendation & Conclusion

4.5. Top investment opportunity

4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

5.1.1. Assessment of the overall impact of COVID-19 on the industry

5.1.2. Pre COVID-19 and post COVID-19 market scenario

Chapter 6. Global Biopharmaceutical CMO And CRO Market, by Source

6.1. Market Snapshot

6.2. Global Biopharmaceutical CMO And CRO Market by Source, Performance - Potential Analysis

6.3. Global Biopharmaceutical CMO And CRO Market Estimates & Forecasts by Source, 2018-2027 (USD Billion)

6.4. Biopharmaceutical CMO And CRO Market, Sub Segment Analysis

6.4.1. Mammalian

6.4.2. Non-mammalian

Chapter 7. Global Biopharmaceutical CMO And CRO Market, by Service

7.1. Market Snapshot

7.2. Global Biopharmaceutical CMO And CRO Market by Service, Performance - Potential Analysis

7.3. Global Biopharmaceutical CMO And CRO Market Estimates & Forecasts by Service, 2018-2027 (USD Billion)

7.4. Biopharmaceutical CMO And CRO Market, Sub Segment Analysis

7.4.1. Contract Manufacturing

7.4.2. Contract Research

Chapter 8. Global Biopharmaceutical CMO And CRO Market, by Product

8.1. Market Snapshot

8.2. Global Biopharmaceutical CMO And CRO Market by Product, Performance - Potential Analysis

8.3. Global Biopharmaceutical CMO And CRO Market Estimates & Forecasts by Product, 2018-2027 (USD Billion)

8.4. Biopharmaceutical CMO And CRO Market, Sub Segment Analysis

8.4.1. Biologics

8.4.2. Biosimilars

Chapter 9. Global Biopharmaceutical CMO And CRO Market, Regional Analysis

9.1. Biopharmaceutical CMO And CRO Market, Regional Market Snapshot

9.2. North America Biopharmaceutical CMO And CRO Market

9.2.1. U.S. Biopharmaceutical CMO And CRO Market

9.2.1.1. Source breakdown estimates & forecasts, 2018-2027

9.2.1.2. Service breakdown estimates & forecasts, 2018-2027

9.2.1.3. Product breakdown estimates & forecasts, 2018-2027

9.2.2. Canada Biopharmaceutical CMO And CRO Market

9.3. Europe Biopharmaceutical CMO And CRO Market Snapshot

9.3.1. U.K. Biopharmaceutical CMO And CRO Market

9.3.2. Germany Biopharmaceutical CMO And CRO Market

9.3.3. France Biopharmaceutical CMO And CRO Market

9.3.4. Spain Biopharmaceutical CMO And CRO Market

9.3.5. Italy Biopharmaceutical CMO And CRO Market

9.3.6. Rest of Europe Biopharmaceutical CMO And CRO Market

9.4. Asia-Pacific Biopharmaceutical CMO And CRO Market Snapshot

9.4.1. China Biopharmaceutical CMO And CRO Market

9.4.2. India Biopharmaceutical CMO And CRO Market

9.4.3. Japan Biopharmaceutical CMO And CRO Market

9.4.4. Australia Biopharmaceutical CMO And CRO Market

9.4.5. South Korea Biopharmaceutical CMO And CRO Market

9.4.6. Rest of Asia Pacific Biopharmaceutical CMO And CRO Market

9.5. Latin America Biopharmaceutical CMO And CRO Market Snapshot

9.5.1. Brazil Biopharmaceutical CMO And CRO Market

9.5.2. Mexico Biopharmaceutical CMO And CRO Market

9.6. Rest of The World Biopharmaceutical CMO And CRO Market

Chapter 10. Competitive Intelligence

10.1. Top Market Strategies

10.2. Company Profiles

10.2.1. Boehringer Ingelheim GmbH

10.2.1.1. Key Information

10.2.1.2. Overview

10.2.1.3. Financial (Subject to Data Availability)

10.2.1.4. Product Summary

10.2.1.5. Recent Developments

10.2.2. Lonza Group AG

10.2.3. Inno Biologics Sdn Bhd

10.2.4. Rentschler Biopharma SE

10.2.5. JRS Pharma

10.2.6. Biomeva GmbH

10.2.7. ProBioGen AG

10.2.8. Fujifilm Diosynth Biotechnologies U.S.A., Inc.

10.2.9. Toyobo Co., Ltd.

10.2.10. Samsung Biologics

Chapter 11. Research Process

11.1. Research Process

11.1.1. Data Mining

11.1.2. Analysis

11.1.3. Market Estimation

11.1.4. Validation

11.1.5. Publishing

11.2. Research Attributes

11.3. Research Assumption

List of Tables

TABLE 1. Global Biopharmaceutical CMO And CRO market, report scope

TABLE 2. Global Biopharmaceutical CMO And CRO market estimates & forecasts by Region 2018-2027 (USD Billion)

TABLE 3. Global Biopharmaceutical CMO And CRO market estimates & forecasts by Source 2018-2027 (USD Billion)

TABLE 4. Global Biopharmaceutical CMO And CRO market estimates & forecasts by Service 2018-2027 (USD Billion)

TABLE 5. Global Biopharmaceutical CMO And CRO market estimates & forecasts by Product 2018-2027 (USD Billion)

TABLE 6. Global Biopharmaceutical CMO And CRO market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 7. Global Biopharmaceutical CMO And CRO market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 8. Global Biopharmaceutical CMO And CRO market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 9. Global Biopharmaceutical CMO And CRO market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 10. Global Biopharmaceutical CMO And CRO market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 11. Global Biopharmaceutical CMO And CRO market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 12. Global Biopharmaceutical CMO And CRO market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 13. Global Biopharmaceutical CMO And CRO market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 14. Global Biopharmaceutical CMO And CRO market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 15. Global Biopharmaceutical CMO And CRO market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 16. U.S. Biopharmaceutical CMO And CRO market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 17. U.S. Biopharmaceutical CMO And CRO market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 18. U.S. Biopharmaceutical CMO And CRO market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 19. Canada Biopharmaceutical CMO And CRO market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 20. Canada Biopharmaceutical CMO And CRO market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 21. Canada Biopharmaceutical CMO And CRO market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 22. UK Biopharmaceutical CMO And CRO market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 23. UK Biopharmaceutical CMO And CRO market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 24. UK Biopharmaceutical CMO And CRO market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 25. Germany Biopharmaceutical CMO And CRO market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 26. Germany Biopharmaceutical CMO And CRO market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 27. Germany Biopharmaceutical CMO And CRO market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 28. RoE Biopharmaceutical CMO And CRO market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 29. RoE Biopharmaceutical CMO And CRO market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 30. RoE Biopharmaceutical CMO And CRO market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 31. China Biopharmaceutical CMO And CRO market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 32. China Biopharmaceutical CMO And CRO market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 33. China Biopharmaceutical CMO And CRO market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 34. India Biopharmaceutical CMO And CRO market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 35. India Biopharmaceutical CMO And CRO market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 36. India Biopharmaceutical CMO And CRO market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 37. Japan Biopharmaceutical CMO And CRO market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 38. Japan Biopharmaceutical CMO And CRO market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 39. Japan Biopharmaceutical CMO And CRO market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 40. RoAPAC Biopharmaceutical CMO And CRO market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 41. RoAPAC Biopharmaceutical CMO And CRO market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 42. RoAPAC Biopharmaceutical CMO And CRO market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 43. Brazil Biopharmaceutical CMO And CRO market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 44. Brazil Biopharmaceutical CMO And CRO market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 45. Brazil Biopharmaceutical CMO And CRO market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 46. Mexico Biopharmaceutical CMO And CRO market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 47. Mexico Biopharmaceutical CMO And CRO market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 48. Mexico Biopharmaceutical CMO And CRO market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 49. RoLA Biopharmaceutical CMO And CRO market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 50. RoLA Biopharmaceutical CMO And CRO market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 51. RoLA Biopharmaceutical CMO And CRO market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 52. Row Biopharmaceutical CMO And CRO market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 53. Row Biopharmaceutical CMO And CRO market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 54. Row Biopharmaceutical CMO And CRO market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 55. List of secondary sources, used in the study of global Biopharmaceutical CMO And CRO market

TABLE 56. List of primary sources, used in the study of global Biopharmaceutical CMO And CRO market

TABLE 57. Years considered for the study

TABLE 58. Exchange rates considered

Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Global Biopharmaceutical CMO And CRO Market Size study, by Source (Mammalian, Non-mammalian), By Service (Contract Manufacturing, Contract Research), By Product (Biologics, Biosimilars) and Regional Forecasts 2021-2027

Contact Us

Drop Us an email at

Similar Reports

Client Testimonials

Maria

David

Sara